Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
quality_manual [2025/01/30 04:26] – admin | quality_manual [2025/02/06 06:24] (current) – admin | ||
---|---|---|---|
Line 13: | Line 13: | ||
- | =====Header===== | + | =====Header===== |
^Name^Unique ID^Edition^Date of Edition^ | ^Name^Unique ID^Edition^Date of Edition^ | ||
|Quality Manual|LSSTH/ | |Quality Manual|LSSTH/ | ||
Line 974: | Line 974: | ||
Biological reference intervals and clinical decision limits will be defined, and their basis recorded, to reflect the patient population served by the laboratory, while considering the risk to patients. {{https:// | Biological reference intervals and clinical decision limits will be defined, and their basis recorded, to reflect the patient population served by the laboratory, while considering the risk to patients. {{https:// | ||
+ | [[Biological Reference Interval]] | ||
**NOTE:** Biological reference values, provided by the manufacturer can be used by the laboratory, if the population base of these values is verified and deemed acceptable by the laboratory | **NOTE:** Biological reference values, provided by the manufacturer can be used by the laboratory, if the population base of these values is verified and deemed acceptable by the laboratory | ||
Line 1011: | Line 1011: | ||
{{https:// | {{https:// | ||
{{https:// | {{https:// | ||
+ | [[Documentary Procedure for validation of examination of result]] | ||
a) The laboratory will have an IQC procedure for monitoring the ongoing validity of examination results, according to specified criteria, that verifies the attainment of the intended quality and ensures validity pertinent to clinical decision making. | a) The laboratory will have an IQC procedure for monitoring the ongoing validity of examination results, according to specified criteria, that verifies the attainment of the intended quality and ensures validity pertinent to clinical decision making. | ||
Line 1053: | Line 1053: | ||
==7.3.7.3 External quality assessment (EQA)== | ==7.3.7.3 External quality assessment (EQA)== | ||
- | |||
- | {{https:// | ||
{{https:// | {{https:// | ||
{{https:// | {{https:// | ||
+ | [[Procedure for Storage, Preparation, | ||
a) The laboratory will monitor its performance of examination methods, by comparison with results of other laboratories. This includes participation in EQA programmes appropriate to the examinations and interpretation of examination results, including POCT examination methods. | a) The laboratory will monitor its performance of examination methods, by comparison with results of other laboratories. This includes participation in EQA programmes appropriate to the examinations and interpretation of examination results, including POCT examination methods. | ||
Line 1139: | Line 1137: | ||
==7.4.1.2 Result review and release== | ==7.4.1.2 Result review and release== | ||
- | Results will be reviewed and authorized prior to release. The laboratory will ensure that authorized personnel review the results of examinations and evaluate them against IQC and, as appropriate, | + | Results will be reviewed and authorized prior to release. The laboratory will ensure that authorized personnel review the results of examinations and evaluate them against IQC and, as appropriate, |
==7.4.1.3 Critical result reports== | ==7.4.1.3 Critical result reports== | ||
- | {{https:// | + | [[7.4.1.3_critical_values|]]{{https:// |
When examination results fall within established critical decision limits: | When examination results fall within established critical decision limits: |